For the quarter ending 2025-06-30, IGMS made $143,623K in revenue. $97,584K in net income. Net profit margin of 67.94%.
| Income Statement | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
| Collaboration revenue | 143,623 | 499 | 1,131* | 516 |
| General and administrative | 9,581 | 11,049 | -5,878* | 18,761 |
| Research and development | 5,863 | 22,337 | 22,428* | 46,142 |
| Impairment and disposal of long-lived assets | 31,917 | 21,889 | - | - |
| Total operating expenses | 47,361 | 55,275 | 16,550* | 64,903 |
| Income (loss) from operations | 96,262 | -54,776 | -15,419* | -64,387 |
| Interest income | 1,322 | - | 3,914 | 2,957 |
| Total other income | 1,322 | - | 3,914* | 2,957 |
| Loss before income tax expense | - | - | -11,505 | -61,430 |
| Net income (loss) | 97,584 | - | -11,505 | -61,430 |
| Basic EPS | 1.59 | -0.86 | -0.191 | -1.01 |
| Diluted EPS | 1.58 | -0.86 | -0.191 | -1.01 |
| Basic Average Shares | 61,462,957 | 61,162,762 | 60,371,295 | 60,657,797 |
| Diluted Average Shares | 61,751,283 | 61,162,762 | 60,371,295 | 60,657,797 |
IGM Biosciences, Inc. (IGMS)
IGM Biosciences, Inc. (IGMS)